News
🇪🇺 EMA Page 20Latest pharmaceutical news, drug approvals, and EMA regulatory updates
Showing 229–240 of 341 articles
Pharmaceutical Intermediates Market to Reach $57 Billion by 2035 as Generic Drug Manufacturing Drives 4.5% Annual Growth
Reuters Pharma Day 1: Key Takeaways for European Markets
Reuters Pharma EU: Day 1 Key Takeaways for Pharma Leaders
Belite Bio Submits New Drug Application for Tinlarebant to Treat Stargardt Disease Following Positive Phase 3 Results
Abivax Presents Obefazimod Phase 3 Data at Digestive Disease Week 2026
Pet Service Holding Reports 2025 Annual Results Amid European Veterinary Regulatory Changes
Femasys Launches FemaSeed Complete Fertility Solution for OB/GYNs at ACOG 2026
Mauna Kea Technologies Secures CE Mark Under New MDR, Expands European Medical Device Approvals
Pembrolizumab Plus Lenvatinib Shows Promise for Rare Clear Cell Gynecological Cancers in Phase 2 Trial
Roche's Gazyva Receives FDA Acceptance for Lupus Treatment Following Positive Phase III Trial Results
Ipsen Receives EU Approval for Ojemda (Tovorafenib) to Treat Pediatric Brain Cancer with BRAF Mutations
Reuters Pharma EU: Key Takeaways and Industry Insights